PRFX
NASDAQPRF Technologies Ltd.
Price$1.06-0.03 (-2.75%)
01:30 PM06:30 PM
News · 26 weeks44+14%
2026-02-012026-07-26
Mix2490d
- SEC Filings15(63%)
- Other9(38%)
Latest news
25 items- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy PlatformsTEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF", "PRF Technologies" or the "Company") today issued a Letter to Shareholders from Efraim Cohen-Arazi, Interim Chief Executive Officer. First-Half 2026 and Recent Highlights: Raised $10 million through the Company's equity line facility, substantially strengthening the balance sheetLayerBio advancing the operational and clinical preparations required to commence the planned Phase 2 clinical trial of OcuRing™-KReported expanded preclinical results for PRF-110, demonstrating sustained 72-hour analgesic activity comparable to an approved, commercially available extended-release benchmarkDeepSolar va
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced that its DeepSolar business unit will participate in Energy Trading Week Europe 2026, taking place September 24–25, 2026, at the Business Design Centre in London. The participation follows several recent platform milestones, including DeepSolar’s participation in the NVIDIA Connect program, as PRF continues to advance GridFeed™, its AI-driven platform for renewable energy trading, market participation and revenue optimization, built on its DeepSolar Predict™ AI engine. According to the event organizers, the conference is expected to bring together more than 2,50
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage AssetsTEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced the expansion of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, with Battery-to-Revenue Intelligence, a new capability designed to extend the platform’s optimization workflows to battery energy storage assets. The announcement follows the Company’s recently completed validation of DeepSolar Predict using real-world European market data, as PRF continues to advance the solution toward planned commercial launch. Battery-to-Revenue Intelligence is designed to help renewable energy operators move beyond battery monitoring
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market DataTEL AVIV, Israel, July 08, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced that its DeepSolar business unit has completed an initial validation phase for DeepSolar Predict™, the Company’s next generation AI-driven revenue optimization platform, marking another step toward the solution’s planned commercial launch. The validation applied real-world historical weather data, renewable energy production records and market data - including utility-scale datasets and market conditions representative of European energy markets - to evaluate the platform’s optimization recommendations and decision-support workflows across day-ahead and intraday
- SECSEC Form EFFECT filed by PRF Technologies Ltd.EFFECT - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form 424B3 filed by PRF Technologies Ltd.424B3 - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved BenchmarkTEL AVIV, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company"), a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced expanded results from its previously reported preclinical study directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study. The expanded results characterize the pharmacokinetic (PK) and tissue-distribution properties of PRF-110 alongside the analgesic efficacy data previously announced. PRF-110
- SECSEC Form F-1 filed by PRF Technologies Ltd.F-1 - PRF Technologies Ltd. (0001801834) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by PRF Technologies Ltd.SCHEDULE 13G/A - PRF Technologies Ltd. (0001801834) (Subject)
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy MarketsTEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today provided an update on the advancement of DeepSolar Predict™, the Company's AI-driven renewable energy revenue optimization platform, as PRF continues to prepare the solution for planned commercial launch. DeepSolar Predict is designed to help renewable energy operators move from production monitoring and standalone forecasting to real-time revenue optimization by combining AI forecasting, storage intelligence and market-driven decision support in a single platform. DeepSolar Predict is being developed with the goal of helping renewable asset owners, operators, and energy
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- PRPRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical StudyTEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company"), a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics for post-operative pain management, today announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110, to ZYNRELEF® (bupivacaine and meloxicam extended-release solution), an approved extended-release product used as a benchmark in the study. PRF-110 is a proprietary, oil-based, viscous, clear extended-release formulation of ropivacaine designed to be deposited directly into the surgical wound bed prior to closure. Th
- SECSEC Form EFFECT filed by PRF Technologies Ltd.EFFECT - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form 424B3 filed by PRF Technologies Ltd.424B3 - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form F-1 filed by PRF Technologies Ltd.F-1 - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form SCHEDULE 13G filed by PRF Technologies Ltd.SCHEDULE 13G - PRF Technologies Ltd. (0001801834) (Subject)
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
- SECSEC Form 6-K filed by PRF Technologies Ltd.6-K - PRF Technologies Ltd. (0001801834) (Filer)
PRFX FAQ
6 questionsWhat does PRF Technologies Ltd. do?
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.Where does PRFX stock trade?
PRF Technologies Ltd. (PRFX) is listed on NASDAQ.What sector and industry is PRFX in?
PRF Technologies Ltd. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did PRF Technologies Ltd. go public?
PRF Technologies Ltd. (PRFX) completed its IPO in 2020.What companies are similar to PRFX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare PRFX side-by-side with any of them on Quantisnow.How can I track PRFX on Quantisnow?
Quantisnow aggregates PRF Technologies Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRFX to receive live email and push alerts on every new disclosure.